Tegavivint Clinical Trials

3 actively recruiting trials across 3 locations

Also known as: BC 2059, BC-2059, BC2059, Tegatrabetan

Filter by location:

Birmingham, Alabama1 trial

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

Children's Hospital of Alabama

Phase 1/2

Atlanta, Georgia1 trial

Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma

Arthur M. Blank Children's Healthcare of Atlanta

Phase 1

Columbus, Ohio1 trial

Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer

Ohio State University Comprehensive Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.